GlaxoSmithKline PLC Press Releases

GSK 
$43.63
*  
0.02
0.05%
Get GSK Alerts
*Delayed - data as of Oct. 21, 2014  -  Find a broker to begin trading GSK now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    GSK After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
ViiV Healthcare Expands Program to Reduce HIV Disparities in Southern U.S.
10/20/2014 9:00:00 AM - PR Newswire
▲0.69 % Price Change since this news event. The Volume Ratio is 0.58.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


GSK receives FDA approval of an additional Promacta® (eltrombopag) indication for use in patients with severe aplastic anaemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST)
8/26/2014 3:52:00 PM - PR Newswire


Multimedia assets now available: ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection
8/25/2014 9:00:00 AM - PR Newswire


ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection
8/22/2014 3:46:00 PM - PR Newswire


GSK receives FDA approval for Arnuity™ Ellipta® (fluticasone furoate) in the US for the treatment of asthma
8/20/2014 3:33:00 PM - PR Newswire


Pernix Therapeutics Closes Acquisition of Treximet. Raises $220m Senior Notes. Issues Updated 2014 Guidance.
8/20/2014 8:00:00 AM - Business Wire


GSK's COPD.com Relaunch Promotes Understanding and Dialogue about COPD
8/5/2014 9:00:00 AM - PR Newswire


Closing for Pernix Transaction to Acquire Treximet® Tablets for Migraine from GSK Delayed
8/4/2014 9:15:00 AM - Business Wire


GSK's Tanzeum™ is now available in pharmacies in the U.S.
7/29/2014 3:31:00 PM - PR Newswire


FDA Approves Flonase® Allergy Relief For Sale Over-The-Counter In The United States
7/24/2014 1:32:00 PM - PR Newswire


First Vaccine Candidate for Malaria is Accepted for EU Regulatory Review
7/24/2014 6:01:00 AM - Business Wire